th official CDC guidance and information (updated 08/12/21).
Understanding the Federal Retail Pharmacy Program for COVID-19 Vaccination: Explains the Federal Retail Pharmacy Program, a collaboration between the federal government, states and territories, and 21 national pharmacy partners and independent pharmacy networks to increase access to COVID-19 vaccination across the United States. This program is one component of the Federal government’s strategy to expand access to vaccines for the American public.
COVID-19 Vaccine Toolkit for School Settings and Childcare Programs: Provides COVID-19 vaccine information, as well as official CDC materials including posters, flyers, letters to staff, social media mesages, newsletter articles, and stickers, for staff in schools and childcare programs.
COVID-19 Vaccines for Teachers, School Staff, and Childcare Workers: Informs staff of the latest, official CDC information about how to get vaccinated.
FDA Approves First COVID-19 Vaccine (Spanish language version): Reports formal approval (08/23/21) of the Pfizer-BioNTech COVID-19 vaccine for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age; and for the administration of a third dose in certain immunocompromised individuals. The FDA, an agency within the U.S. Department of Health and Human Services [DHHS], protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use.
What FDA's Full Approval of Pfizer-BioNTech COVID-19 Vaccine Means: Explains the parameters and significance of the 8/23/21 full authorization of the Pfizer COVID-19 vaccine. The American Medical Association [AMA] report explains the Pfizer vaccine (will be marketed as Comirnaty) is fully approved for use in individuals ages 16 and older to prevent COVID-19 disease. A recent survey from the Kaiser Family Foundation had found that 30% of unvaccinated people said they were waiting for COVID-19 vaccines to receive full approve before taking the next step to get vaccinated. A joint statement from the AMA, American Hospital Association and American Nurses Association states, “We are there now. This vaccine is fully approved. If uncertainty was holding you back, now is the time to act.”
Video Series: Communicating about Vaccines: Offers a series of short videos to help public health advocates, staff in local health departments, and others communicate more effectively about COVID-19 and how it intersects with other important public health issues. In the initial (4 minutes) video, Berkeley Media Studies Group [BMSG] offers strategic communication tips by investing in trusted messengers.
COVID-19 Vaccine Breakthrough Cases: Data from the States: Provides state-level data on COVID-19 breakthrough cases, hospitalizations and deaths. While COVID-19 vaccines are highly effective, a small share of fully vaccinated individuals do become infected. These rare “breakthrough cases” are expected, as no vaccine is 100% effective. While the Centers for Disease Control and Prevention [CDC] presents aggregate data at the national level, this Kaiser Family Foundation site serves as a single repository for data by state on breakthrough infections that can support data-based decision-making indicated by federal guidance for schools and communities. The Kaiser Family Foundation’s Vaccine Monitor presents data from an ongoing research project tracking the public’s attitudes and experiences with COVIED-19 vaccinations.
States Plan for Vaccinating Their Populations against COVID-19: Provides a compendium of every state’s COVID-19 vaccination distribution and administration plans by Priority Phases, in light of current (2/19/21) federal guidance, and limited vaccine supplies. This state-by-state compendium is compiled and updated by the National Academy for State Health Policy [NASHP].
Tracking COVID-19 Vaccine Distribution by State: How Ma